Mark L. Smythe

6.9k total citations · 2 hit papers
49 papers, 5.8k citations indexed

About

Mark L. Smythe is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Mark L. Smythe has authored 49 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Mark L. Smythe's work include Chemical Synthesis and Analysis (25 papers), Click Chemistry and Applications (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Mark L. Smythe is often cited by papers focused on Chemical Synthesis and Analysis (25 papers), Click Chemistry and Applications (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Mark L. Smythe collaborates with scholars based in Australia, Denmark and United States. Mark L. Smythe's co-authors include Gregory T. Bourne, Douglas A. Horton, Garland R. Marshall, Mark von Itzstein, David Ryan, Michael S. Pegg, Richard C. Bethell, Stuart W. Oliver, Joseph Varghese and Wen‐Yang Wu and has published in prestigious journals such as Nature, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Mark L. Smythe

48 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures

2003 2.7k citations Douglas A. Horton, Gregory T. Bourne et al. Chemical Reviews profile →
Rational design of potent sialidase-based inhibitors of influenza virus replication

1993 1.5k citations Mark von Itzstein, Wen‐Yang Wu et al. Nature profile →

Peers

Countries citing papers authored by Mark L. Smythe

Since Specialization

Citations

This map shows the geographic impact of Mark L. Smythe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Smythe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Smythe more than expected).

Fields of papers citing papers by Mark L. Smythe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Smythe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Smythe. The network helps show where Mark L. Smythe may publish in the future.

Co-authorship network of co-authors of Mark L. Smythe

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Smythe. A scholar is included among the top collaborators of Mark L. Smythe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Smythe. Mark L. Smythe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of complement-mediated inflammation in the mdx mouse model of duchenne muscular dystrophy by PK007 2025 ·Immunobiology ·(unknown), (unknown), (unknown), Mark L. Smythe, Peter G. Noakes, Miranda D. Grounds	0
2	Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma 2024 ·Nature Communications ·Md Ashik Ullah, Sonja Rittchen, Jia Li, Bodie F. Curren, (unknown), (unknown), (unknown), (unknown), Md Al Amin Sikder, Ridwan Bin Rashid, (unknown), Mary Lor, Mark L. Smythe, Simon Phipps	1
3	Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload 2017 ·American Journal of Hematology ·Gregory T. Bourne, Li Zhao, Ashok Bhandari, Brian Frederick, (unknown), Vinh T. Tran, Jenny Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Mark L. Smythe, David Liu	3
4	Sigma-class glutathione transferases 2011 ·Drug Metabolism Reviews ·Jack U. Flanagan, Mark L. Smythe	43
5	Conformational searching using a population‐based incremental learning algorithm 2011 ·Journal of Computational Chemistry ·S.M. Long, (unknown), Peter D. Adams, Paul J. Darwen, Mark L. Smythe	7
6	Defining scaffold geometries for interacting with proteins: geometrical classification of secondary structure linking regions 2010 ·Journal of Computer-Aided Molecular Design ·(unknown), (unknown), (unknown), Darryn Bryant, Peter D. Adams, Mark L. Smythe	2
7	Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D 2 synthase 2009 ·European Journal of Medicinal Chemistry ·(unknown), Aaron J. Oakley, Angelika N. Christ, Alan G. Clark, John D. Hayes, (unknown), David Hume, Philip G. Board, Mark L. Smythe, Jack U. Flanagan	18
8	Cyclic tetrapeptides via the ring contraction strategy: chemical techniques useful for their identification 2008 ·Organic & Biomolecular Chemistry ·Douglas A. Horton, Gregory T. Bourne, (unknown), (unknown), Carolyn Jacobs, Alun Jones, Andreas Rühmann, (unknown), Mark L. Smythe	34
9	A Convenient Method for Synthesis of Cyclic Peptide Libraries 2005 ·Humana Press eBooks ·Gregory T. Bourne, (unknown), (unknown), Paul J. Darwen, Marc R. Campitelli, Douglas A. Horton, (unknown), (unknown), (unknown), Mark L. Smythe	3
10	Intramolecular disulphide bond arrangements in nonhomologous proteins 2005 ·Protein Science ·(unknown), (unknown), Mark L. Smythe	14
11	Topological side-chain classification of β-turns: Ideal motifs for peptidomimetic development 2005 ·Journal of Computer-Aided Molecular Design ·(unknown), (unknown), Wim Meutermans, Gregory T. Bourne, Peter R. Andrews, Mark L. Smythe	12
12	A safety catch linker for Fmoc-based assembly of constrained cyclic peptides 2005 ·Journal of Peptide Science ·(unknown), Gregory T. Bourne, Mark L. Smythe	10
13	Increased Site 1 Affinity Improves Biopotency of Porcine Growth Hormone 2004 ·Journal of Biological Chemistry ·Yu Wan, (unknown), Bojiang Shen, Mark L. Smythe, Michael J. Waters	25
14	Development of small molecules that mimic the binding of ω-conotoxins at the N-type voltage-gated calcium channel 2004 ·Molecular Diversity ·Christina I. Schroeder, Mark L. Smythe, Richard J. Lewis	31
15	The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures breakdown → 2003 ·Chemical Reviews ·Douglas A. Horton, Gregory T. Bourne, Mark L. Smythe	2737
16	Exploring privileged structures: the combinatorial synthesis of cyclic peptides 2002 ·Journal of Computer-Aided Molecular Design ·Douglas A. Horton, Gregory T. Bourne, Mark L. Smythe	88
17	Proteolysis of human hemoglobin by schistosome cathepsin D 2001 ·Molecular and Biochemical Parasitology ·Paul J. Brindley, Bernd H. Kalinna, (unknown), Burton J. Bogitsh, (unknown), Danielle J. Smyth, (unknown), Giovanni Abbenante, Ross I. Brinkworth, David P. Fairlie, Mark L. Smythe, Peter J. Milburn, Helle Bielefeldt‐Ohmann, (unknown), Donald P. McManus	97
18	Exploring privileged structures: The combinatorial synthesis of cyclic peptides 2000 ·Molecular Diversity ·Douglas A. Horton, Gregory T. Bourne, Mark L. Smythe	86
19	Proteolytic degradation of host hemoglobin by schistosomes1Note: Nucleotide sequences data reported in the paper have been submitted to the GenBank™ data base with the accession numbers L41346 and U77932.1 1997 ·Molecular and Biochemical Parasitology ·Paul J. Brindley, Bernd H. Kalinna, John P. Dalton, Sharon R. Day, (unknown), Mark L. Smythe, Donald P. McManus	132
20	Rational design of potent sialidase-based inhibitors of influenza virus replication breakdown → 1993 ·Nature ·Mark von Itzstein, Wen‐Yang Wu, Gaik B. Kok, Michael S. Pegg, Jeffrey C. Dyason, Betty Jin, (unknown), Mark L. Smythe, (unknown), Stuart W. Oliver, Peter M. Colman, Joseph Varghese, David Ryan, (unknown), Richard C. Bethell, (unknown), J. M. Cameron, Charles R. Penn	1465

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact